Research Trial for Cancer Patient’s
Our Clinical Director Professor Gary Lee and his team have been awarded a $100,000 Cancer Council WA Grant for a research trial into malignant pleural effusion.
What is malignant pleural effusion?
Malignant pleural effusion is the build up of fluid around the chest cavity causing breathlessness for some cancer patients.
Professor Lee and his team have developed a new treatment where a indwelling pleural catheter (IPC) is placed in a patient’s chest, allowing excess fluid to be drained. This treatment plan is non-evasive and can be done at home instead of having to go into hospital.
The aim of IPC is to help patients breathe easier and offers a better quality of life.
Professor Lee’s was interviewed on 6PR recently explaining the research trial and what is involved in the new therapy.
More about the trial
Australasian Malignant Pleural Effusion (AMPLE) Trial-2
The AMPLE-2 trial will randomize 86 patients with cancer effusions to daily or symptom-guided drainage regimes post-IPC insertion. The primary aim of this project is to measure the degree of breathlessness experienced by the patient every day for the first 60 days.
The aim of the trial is to determine which regime is superior in improving clinical outcomes.